I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Today, dental implants provide a predictive treatment for prosthetic rehabilitation of edentulous patients. Sufficient volume and density of the alveolar bone for implant integration and load bearing are factors of utmost importance for a good result. Reduced bone height below the maxillary sinus in the posterior maxillary region is a hinderance to successful implant placement. Not only there is bone resorption but also increased pneumatization of the maxillary sinus which renders the ridge inadequate for implant procedures.\[[@ref1]\] Thus, the amount of bone beneath the maxillary sinus is often very limited. The technique of sinus floor elevation has expanded prosthetic options by enabling the placement of additional implant support in maxillary segments with atrophic ridges and pneumatized sinuses.

Augmentation of the maxillary sinus was first described by Tatum and published as a clinical study by Boyne and James.\[[@ref2]\] In the technique described by Tatum access to sinus was through the crest. This technique was later replaced with lateral sinus osteotomy which was considered to be more versatile and practical.\[[@ref3]\] After elevating the sinus lining from the floor, bone graft was placed (autogenous is considered to be a gold standard). Implant can then be installed immediately or at a later stage depending on residual bone height (RBH). Summers described an alternative technique for sinus floor elevation using osteotomes. With this technique, the floor of the maxillary sinus is elevated using access through the alveolar ridge utilizing different osteotomes. Bone graft is added followed by implant placement.\[[@ref3][@ref4]\]

The use of bone grafts for sinus augmentation, irrespective of the technique utilized has been associated with high success rate, although it has certain demerits such as second surgical site for autogenous bone harvesting, increased rate of complications, higher cost, and increased surgical time. It was a report by Lundgren *et al.* which pointed toward spontaneous bone formation below the sinus floor after the cyst enucleation exhibiting a tendency in the Schneiderian membrane potential for bone formation.\[[@ref5]\] What followed this were a number of studies, in which successful implant placement and rehabilitation were carried out without using bone grafts. These studies have shown that new bone formation occurs after sinus augmentation due to the creation of void with the presence of blood clot which induces bone deposition based on the principles of guided tissue regeneration.\[[@ref4][@ref6][@ref7][@ref8]\] Furthermore, the osteogenic potential of maxillary sinus membrane has come into the picture.\[[@ref9][@ref10][@ref11]\]

With more studies indicating the successful implants placement below the sinus floor without additional bone grafting procedures, the focus was shifted to develop a technique which was quicker and less invasive. Graftless sinus lift is applicable to both lateral and crestal approach for sinus lifting with high success rate.\[[@ref6][@ref7][@ref8][@ref12][@ref13][@ref14]\] The advantage of the crestal procedure is not only more conservative, easier, and less invasive but also causes lateral compression and expansion of the adjacent bone. Added advantage is superior manual control in determining the implant axis which prevents dehiscence and fenestration.\[[@ref15]\] With these points in the background, the study was aimed to evaluate osteotome sinus floor elevation (OSFE) without using bone graft.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This prospective controlled clinical trial was conducted on randomly selected patients who had reported to our department. Approval from the Institutional Ethical Committee was obtained to carry out the study. A total of 26 implants were placed in 21 patients and evaluated clinically and radiographically over a period of 6 months. Intra-oral periapical radiographs were taken to determine RBH, endosinus bone (ESB), and crestal bone level (CBL). All the patients were explained about the procedure and written informed consent was obtained.

Inclusion criteria {#sec2-1}
------------------

Inclusion criteria were as follows:

Patients who required implant treatment in the posterior maxillaBone height between the crest and sinus floor was not ≥8 mm at least on one side of the implant.

Exclusion criteria {#sec2-2}
------------------

Exclusion criteria were as follows:

Patients with a history of maxillary sinus diseaseImmunocompromised conditionsUnrealistic expectations and psychological problems.

For clinical evaluation following criteria were considered:

Implant stability: Evaluated clinically using instruments on each side of implant to determine if the mobility is presentRBH which was measured on both mesial and distal sides of each implant. It was determined by measuring the distance between the most apical bone level contacting the implant and alveolar crest level on each sideESB which was measured by a line parallel to implant axis drawn from most coronal implant thread to most apical implant-bone contactCBL which was determined by a line parallel to implant between the most apical implant thread and most coronal implant-bone contact.\[[@ref5][@ref6]\]

The vertical bone height below the sinus floor was measured radiographically using a paralleling kit and metal grid with 1 mm × 1 mm box for measurement.

Lignocaine hydrochloride 2% with adrenaline 1:80,000 was used for local anesthesia. A mid crestal incision without any releasing incisions was placed for flap elevation \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. Full thickness muco-periosteal flap was raised to expose the edentulous area. Cortical bone perforation was done using an initial perforator drill followed by the pilot drill. Proper angled osteotomes were used in increasing diameter to prepare the site for implant placement \[[Figure 3](#F3){ref-type="fig"}\]. With the help of sinus osteotomes, sinus floor was then broken by gentle malleting and pushed axially elevating the Schneiderian membrane. Implants were placed in the prepared osteotomy site \[[Figure 4](#F4){ref-type="fig"}\]. The flap was sutured back for submerged healing \[[Figure 5](#F5){ref-type="fig"}\]. Post operative radiographs were taken at 7^th^ postoperative day \[[Figure 6](#F6){ref-type="fig"}\] and then after the 3^rd^ \[[Figure 7](#F7){ref-type="fig"}\] and 6^th^ month \[[Figure 8](#F8){ref-type="fig"}\]. At the end of the 6^th^ month, the cover screw was removed, and the gingival former was placed. The gingival former was removed after 10 days, the impression post was screwed, and the impression was made with addition silicon and sent to the dental laboratory for the fabrication of metal-ceramic prosthesis. The implants were radiographically evaluated for the changes in RBH, ESB, and CBL, 1 week, 3 months, and 6 months, respectively, after implant placement. These radiographs were taken using a 1 mm^2^ metallic grid kept over the X-ray film while taking the radiographs with a long-cone paralleling technique.
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![Preparation of osteotomy using osteotome](AMS-9-96-g003){#F3}
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Radiographic analysis {#sec2-3}
---------------------

All the three parameters, RBH, ESB, and CBL were measured on both mesial and distal sides of each implant immediately and after 3 months and 6 months of implant placement. These radiographs were taken using a 1 mm^2^ metallic grid kept over the X-ray film while taking the radiographs with a long-cone paralleling technique. To provide uniformity in the procedure for taking radiographs, the following steps were carried out:

Film holder (Rinn-Dentsply) was used for all the patientsThe distance of the focus to dental film was regulated by the apparatus itself0.8 s exposure time in all casesEach imaging session was performed using the same dental X-ray apparatus.

All the three parameters, RBH, ESB, and CBL were measured on both mesial and distal sides of each implant after implant placement, 3 months and 6 months after implant placement. For precise measurements, the distance between the squares of the grid was counted.

The RBH was measured at the mesial and distal implant sides on the radiographs. It was determined by measuring the vertical distance between the most apical bone level contacting the implant and the alveolar crest level on each sideThe ESB height was measured on both sides of the implant parallel to the implant axis from the most coronal implant thread to the most apical visible implant-bone contact. An increase in the distance between the coronal reference point and the most apical bone contact after 6 months indicated ESB gainThe CBL was determined on the mesial and distal implant sides parallel to the implant axis, between the most apical implant thread and the most coronal bone--implant contact. A decrease in this vertical distance between the reference point and the most coronal bone-implant contact on consecutive radiographs indicated loss of crestal bone. An increase in this distance indicated a crestal bone gain.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

All the implants were clinically and radiographically stable at the end of 6 months of follow-up. Twenty implants were Pitt Easy Puretex of 10 mm length and six were 12 mm in length. Eighteen implants (69.23%) were standard implants with a diameter of 4 mm, 6 (23.1%) were wide-body implants with a diameter of 4.9 mm, and the 2 (7.6%) implants were with a reduced diameter of 3.25 mm. The most common site was the first molar with 40%. The second most common position was the second molar with 33%, and the third most common position was second premolar with 26% of the implants. The mean healing time for abutment tightening was 6 months, by which time, all implants were clinically stable. Radiographs taken 6 months after implant placement showed that all implants had gained ESB. Pre- and postoperative RBH, ESB, and CBL were compared using the *t*-test.

Residual bone height {#sec2-4}
--------------------

Mean RBH immediately after implant placement was 6.80 ± 1.89 mm on mesial side and 5.93 ± 1.33 mm on distal side which increased to 7.93 ± 1.16 mm on mesial side and 7.52 ± 1.46 mm on distal side after 6 months \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\]. This increase of RBH was found to be statistically significant \[[Graph 1](#F9){ref-type="fig"}\].

###### 

Residual bone height mesial side (comparison at different time intervals)

  RBH        Mean±SD     SEM    Mean difference   *t*      *P*
  ---------- ----------- ------ ----------------- -------- ---------
  7 days     6.80±1.69   0.44   −0.400            −1.492   0.158
  3 months   7.20±1.61   0.42                              
  7 days     6.80±1.69   0.44   −1.133            −2.939   0.011\*
  6 months   7.93±1.16   0.30                              
  3 months   7.20±1.61   0.42   −0.733            −2.323   0.036\*
  6 months   7.93±1.16   0.30                              

\*Statistically significant. SD=Standard deviation; SEM=Standard error of the mean; RBH=Residual bone height

###### 

Residual bone height distal side (comparison at different time interval)

  RBH        Mean±SD     SEM    Mean difference   *t*      *P*
  ---------- ----------- ------ ----------------- -------- -----------
  7 days     5.93±1.33   0.34   −1.133            −2.656   0.019\*
  3 months   6.30±1.70   0.44                              
  7 days     5.93±1.33   0.34   −2.067            −6.254   \<0.001\*
  6 months   7.52±1.46   0.38                              
  3 months   6.30±1.70   0.44   −0.933            −3.836   0.002\*
  6 months   7.52±1.46   0.38                              

\*Statistically significant. SD=Standard deviation; SEM=Standard error of the mean; RBH=Residual bone height

![Residual bone height](AMS-9-96-g009){#F9}

Endosinus bone height {#sec2-5}
---------------------

The mean ESB was 5.13 ± 1.41 mm on mesial side and 5.0 ± 1.85 mm on distal side. Postoperatively, ESB increased to 6.27 ± 1.21 mm and 7.10 ± 1.14 mm after 3 months and 6 months, respectively, on mesial side, and 6.07 ± 1.02 mm and 6.99 ± 1.04 mm after 3 months and 6 months, respectively, on distal side \[Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\]. This postoperative increase in ESB was found to be statistically significant. At the end of 6-month follow-up, all implants had gained ESB \[[Graph 2](#F10){ref-type="fig"}\].

###### 

Endosinus bone mesial side (comparison at different time interval)

  ESBH       Mean±SD     SEM    Mean difference   *t*      *P*
  ---------- ----------- ------ ----------------- -------- -----------
  7 days     5.13±1.41   0.36   −1.133            −4.076   0.001\*
  3 months   6.27±1.21   0.31                              
  7 days     5.13±1.41   0.36   −2.233            −7.751   \<0.001\*
  6 months   7.10±1.14   0.29                              
  3 months   6.27±1.21   0.31   −1.100            −4.172   0.001\*
  6 months   7.10±1.14   0.29                              

\*Statistically significant. SD=Standard deviation; SEM=Standard error of the mean; ESBH=Endo Sinus Bone Height

###### 

Endosinus bone distal side (comparison at different time interval)

  ESBH       Mean±SD     SEM    Mean difference   *t*      *P*
  ---------- ----------- ------ ----------------- -------- ---------
  7 days     5.00±1.85   0.48   −1.067            −2.268   0.040\*
  3 months   6.07±1.02   0.26                              
  7 days     5.00±1.85   0.48   −1.533            −3.976   0.001\*
  6 months   6.99±1.04   0.27                              
  3 months   6.07±1.02   0.26   −0.467            −2.168   0.050
  6 months   6.99±1.04   0.27                              

\*Statistically significant. SD=Standard deviation; SEM=Standard error of the mean; ESBH=Endo Sinus Bone Height

![Endosinus bone height](AMS-9-96-g010){#F10}

Crestal bone level {#sec2-6}
------------------

CBL after implant placement on mesial and distal sides was 8.27 ± 1.55 mm and 7.83 ± 1.46 mm, respectively. CBL 6 months after implant placement was 7.67 ± 1.11 mm mesially and 7.37 ± 1.56 mm distally. This decrease in CBL in the 6 months span was not found to be statistically significant \[Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}\]. The mean crestal bone loss in the period of 6 months was found to be 0.6 mm mesially and 0.46 mm distally \[[Graph 3](#F11){ref-type="fig"}\].

###### 

Crestal bone level mesial side (comparison at different time interval)

  CBL        Mean±SD     SEM    Mean difference   *t*     *P*
  ---------- ----------- ------ ----------------- ------- ---------
  7 days     8.27±1.55   0.40   0.433             1.992   0.066
  3 months   7.83±1.25   0.32                             
  7 days     8.27±1.55   0.40   0.600             2.500   0.025\*
  6 months   7.67±1.11   0.29                             
  3 months   7.83±1.25   0.32   0.167             0.813   0.430
  6 months   7.67±1.11   0.29                             

\*Statistically significant. SD=Standard deviation; SEM=Standard error of the mean; CBL=Crestal bone level

###### 

Crestal bone level distal side (comparison at different time intervals)

  CBL        Mean±SD     SEM    Mean difference   *t*     *P*
  ---------- ----------- ------ ----------------- ------- -------
  7 days     7.83±1.46   0.38   0.367             1.018   0.326
  3 months   7.47±1.26   0.33                             
  7 days     7.83±1.46   0.38   0.467             1.156   0.267
  6 months   7.37±1.56   0.40                             
  3 months   7.47±1.26   0.33   0.100             0.494   0.629
  6 months   7.37±1.56   0.40                             

SD=Standard deviation; SEM=Standard error of the mean; CBL=Crestal bone level

![Crestal bone level](AMS-9-96-g011){#F11}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

An adequate quantity and quality of bone are extremely indispensable for successful implant therapy. The posterior edentulous maxilla presents special challenges for implant placement. Most important among these is the presence of the maxillary sinus. After extraction, it is frequently observed that the sinus floor is close to the alveolar crest. The rehabilitation of the posterior maxilla depends on the amount of bone present below the sinus.\[[@ref1]\]

The present study evaluated ESB formation and crestal bone loss after OSFE without using a bone graft.

In the past 40 years, sinus elevation surgery has come a long way. With possibilities of new horizons thanks to better understanding and material knowledge, today more emphasis is laid on techniques which are conservative, cost effect, and proficient with higher success rate. The OSFE causes lateral compression and expansion of the adjacent bone. This is especially useful in thin atrophic ridges and type III and type IV bone quality (Lekholm and Zarb classification). This technique has documented reduced perioperative complications and patient discomfort and has shown a good success rates.\[[@ref8][@ref12][@ref13][@ref14][@ref16][@ref17][@ref18][@ref19]\]

A similar result was attained in our study, where the site selected for implant placement was maxillary posterior region. Osteotomes have desirable effect of preserving alveolar bone width and height. The spongy (or cancellous) bone present in the maxilla allows perforation, lateral compression, and expansion of the adjacent bone.\[[@ref15]\]

All the implants in the present study using OSFE osseointegrated within 6 months of placement. This result is comparable to a study by Nedir *et al.*, where the same technique had a 100% survival rate after 1 and 3 years of follow-up.\[[@ref12][@ref13]\] Leblebicioglu *et al.* had a success rate of 97.3% after 25 months of loading.\[[@ref20]\] A study by Lai *et al.* had cumulative survival rate of 95.71% and concluded that OSFE with and without bone grafts gives similar result.\[[@ref19]\] Similar cumulative survival rate was seen in a study by Pjetursson *et al.*\[[@ref18]\] Winter *et al.* placed 58 implants using sinus/alveolar crest tenting and had a survival rate of 91%.\[[@ref21]\] Fugazzotto placed implants using modified trephine/osteotome approach and got success rate of 98.3% after 4 years.\[[@ref17]\] Gabbert *et al.* showed survival rate to be above 94% in implants placed with indirect sinus lift.\[[@ref16]\]

The most commonly described intra-operative complication of sinus floor elevation using OSEF is perforation of the Schneiderian membrane because of the indirect view for the elevation of sinus floor. To check the membrane integrity, Valsalva maneuver is done. A perforation is indicated when air bubbles are found. Minor perforations do not usually need treatment, because the membrane folds on itself.\[[@ref16]\] During elevation in this study, implant treatment was completed in all 26 sites. All patients were asked to do Valsalva maneuver after preparation of the osteotomy site. If membrane perforation was detected, the procedure was not abandoned and implants were placed. In the present study, it was recorded in 1 patient (3.8%). In a study by Nedir *et al.*, membrane perforation was recorded to be 4.29%.

A systematic review of sinus floor elevation found nongrafted maxillary sinus floor elevation seems to be characterized by new bone formation as well as high implant survival rate which was comparable to bone graft-assisted maxillary sinus floor augmentation. It also quotes that the main rationale for bone grafting is to improve implant stability and act as a space maintainer. The key factor affecting the primary stability of dental implants is RBH and its quality could be improved independent of the presence of grafting materials through peri-implant bone condensation.\[[@ref22]\]

Similarly, a recent individual and aggregate data meta-analysis evaluating prospective and retrospective studies of direct maxillary sinus elevation without bone grafting found it to safe and effective technique with high survival rates. The study also quotes the advantages of blood clot present under the Schneiderian membrane for new bone formation which includes no requirement of donor site for bone harvesting, no risk of failure of graft material, reduced cost of the surgical procedure, and better patient acceptance.\[[@ref23]\]

In the present study, no alloplastic or autogenous bone graft was used. None of the implants failed during the follow-up period. All the implants gained ESB. Clinical observations of bone formation in sinus lifting procedure without grafting bone substitutes have been observed, but the biological nature of bone regeneration in sinus lifting procedures is largely speculative. A number of explanations have been proposed.

A theoretical source of bone-forming cells is the periosteum of the lifted sinus membrane. An *in vitro* study by Srouji *et al.* has indicated that maxillary Schneiderian sinus membrane has innate osteogenic potential and its possible contribution to bone regeneration in sinus lifting procedures.\[[@ref9][@ref10]\] This is further supported by a case report by Jung *et al.* in which an impacted tooth was removed using sinus elevation and after 5 months of healing, the space between the sinus floor and the socket was filled with new bone. The author concluded that the osteogenic activity of sinus mucosa and the blood clot in the extraction socket beneath the elevated sinus would have been important factors in this spontaneous bone formation\[[@ref11]\]Presence of blood clot beneath the sinus floor and tenting of the sinus by the implants. A retrospective evaluation of direct sinus lift without bone graft questioned the use of bone grafting materials for the same. The study summarized that the presence of an enclosed chamber with periosteum on lateral aspect and sinus membrane and bone superiorly with implant fixtures providing vertical stops for creation of space to the blood clot resulted in the formation of bone.\[[@ref6]\] This blood clot releases a number of growth factors. The presence of growth factors and cytokines confers osteoinductive activity to the clot which promotes bone formation.\[[@ref6][@ref7][@ref8][@ref23][@ref24]\]

This procedure showed that elevation of the sinus membrane alone, without additional grafting material in case of OSFE is able to create a space for predictable bone formation beyond the sinus floor. Despite a limited RBH, a healing period of 6 months was found to be sufficient to resist a torque of 35Ncm applied during abutment tightening. Radiologically, formation of a new bone structure delimiting the sinus floor was identified.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Placing implants in the atrophic posterior maxillary region using OSFE without simultaneous grafting can be a predictable procedure. Healing was predictable and therefore, the procedure reduced the number of surgical interventions, treatment time, and cost of implant placement in the atrophic posterior maxilla. The procedure can be immensely gratifying to the clinician and especially to the patients as it reduces the total span of treatment. Due to the small sample size and short duration of the study, the long-term survival rate cannot be inferred, for which a long-term study and bigger sample size are warranted.
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